American Association for the Advancement of Science, Science Signaling, 600(12), 2019
DOI: 10.1126/scisignal.aaw8288
Export citation
Search in Google Scholar
Full text: Unavailable
A weak KRAS G13D -NF1 interaction explains why EGFR inhibitors show efficacy in certain CRC patients.